Rejected diet drug staging a comeback

It's the drug that could push dieters to the brink of a heart attack -- and it may be coming soon to a pharmacy near you.

The drug Contrave has been linked to increased blood pressure levels and pulse rates -- which is why the FDA actually REJECTED it earlier this year. (Trust me, I was as surprised as you are.)

But when the company that makes the drug stood up to the FDA, the agency backed down. (Now THERE'S the FDA we've all come to know and hate.)

When the feds rejected the med, they demanded a major long-term study to make sure the drug's possible heart risks wouldn't kill too many people.

That study never happened.

Instead, they ended up signing off on a much less ambitious two-year study that proves absolutely nothing. And you know what that means. When this drug eventually hits the market, you'll be the guinea pig that determines the real heart risks.

And believe me, there WILL be risks: Contrave isn't just one potentially bad med. It's a two-fer -- a powerful antidepressant and a risky anti-addiction drug rolled into one. And the blood pressure and pulse problems are only the beginning.

Patients in clinical trials suffered headaches, nausea, and more -- with one battling a gall bladder infection and another coming down with seizures. It's no wonder 40% of trial participants DROPPED OUT.

If that's not enough to keep you away from the med, consider this: It doesn't even work!

As little as 40 percent of the people who took it in clinical trials experienced a loss in body weight of 5 percent or more -- meaning obese people who pop these pills will become slightly less obese pill-poppers... if they manage to lose any weight at all.

But you don't need to wait for the next risky diet drug to drop those pounds. There are safe and natural ways to get the job done right, and they start with what's on your dinner plate.

For more on the best diets -- including the low-rated lifestyle that's moving to the top of my list -- check out the September issue of the Douglass Report.

Not a subscriber? Sign up here -- unlike those meds, my newsletter comes with a risk-free guarantee.